The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry
Open accessThe DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index; 79 of the 113 sources its claims cite were checked for support.
Abstract
The etiology of psychiatric disorders is complex, involving both genetic and environmental factors with emerging evidence suggesting that epigenetic modifications, including DNA methylation, histone modifications, and non-coding RNA regulation, significantly contribute to mental health. The epigenome influences the development of psychiatric disorders and human behavior and may be considered in clinical observations. Epigenetic changes have been well-established in BDNF , COMT , FKBP5 , NR3C1 , SLC6A4 , and DRD2 , genes associated with psychiatric disorders, including schizophrenia, major depressive disorder (MDD), bipolar disorder (BP), post-traumatic stress disorder (PTSD), and autism spectrum disorder (ASD). Therefore, these epigenetic marks have the potential to be suitable biomarkers for diagnostics, as predictors of prognosis, and for the development of personalized treatments. By exploring the role of clinically relevant epigenetic genes, we review the role of the epigenome in the context of psychiatric disorders and human behavior; and we consider that these changes may be observed in the context of precision psychiatry. This review synthesizes findings from over 100 original research articles and reviews spanning a range of clinical studies. Despite promising associations, challenges in the onset of precision psychiatry, such as tissue heterogeneity, small sample sizes, and lack of replication, are likely to limit translation into clinical practice. Future research in precision psychiatry will help identify clinically actionable epigenetic biomarkers, ushering in an era of genomic medicine in psychiatry.
Overview
CoChat Summary
TL;DR
This narrative review summarizes epigenetic mechanisms—DNA methylation, histone modifications, non-coding RNAs, and chromatin remodeling—and their roles in psychiatric disorders, focusing on BDNF, COMT, FKBP5, NR3C1, SLC6A4, and DRD2. It argues these marks may support precision psychiatry as biomarkers for diagnosis, prognosis, and treatment response, but translation is limited by tissue heterogeneity, small samples, lack of replication, and other methodological challenges.
Key findings
- Epigenetic changes are well-established in BDNF, COMT, FKBP5, NR3C1, SLC6A4, and DRD2 and are associated with schizophrenia, MDD, bipolar disorder, PTSD, ASD, ADHD, OCD, AUD, and SUD. Examples include BDNF promoter hypermethylation reducing BDNF expression, NR3C1 exon 1F hypermethylation after childhood adversity impairing glucocorticoid receptor/HPA-axis regulation, and FKBP5 demethylation/upregulation linked to stress reactivity.
- Epigenetic marks have potential clinical utility as biomarkers for diagnostics, prognosis, relapse risk, and personalized treatment. The review states that methylation of NR3C1, BDNF, and FKBP5 may differentiate subtypes of MDD, PTSD, or schizophrenia; low BDNF methylation correlates with better SSRI response, and high NR3C1 methylation predicts poorer CBT response in PTSD.
- Experimental epigenetic therapies include HDAC inhibitors such as valproic acid, sodium butyrate, and Vorinostat (SAHA); BET inhibitor JQ1; miRNA-based therapies involving miR-124, miR-132, miR-135, and miR-146a; and CRISPR/dCas9 epigenetic editing approaches, mostly in preclinical models.
- The review synthesizes findings from over 100 original research articles and reviews. It concludes that challenges such as tissue heterogeneity, small sample sizes, and lack of replication are likely to limit translation into routine clinical practice.
Methods
- Narrative review of clinically relevant epigenetic mechanisms, candidate genes, and precision psychiatry applications.
- The paper states it synthesizes findings from over 100 original research articles and reviews spanning a range of clinical studies.
- No primary data collection or systematic quantitative synthesis is reported; the review summarizes mechanistic, candidate-gene, and clinical-implication literature.
Limitations
- Stated: limited access to brain tissue means sampling often relies on blood, saliva, or postmortem samples that may not reflect CNS changes; cell-type specificity and bulk tissue analyses can obscure cellular differences; epigenetic marks are dynamic and temporally variable; different assays can yield inconsistent results; large-scale reference datasets are predominantly from individuals of European ancestry; confounders include lifestyle, socioeconomic factors, substance use, and comorbid medical conditions; epigenetic findings are not yet validated for routine psychiatric practice; and an exclusive focus on epigenetics risks oversimplifying disease etiology.
- Evident from the text: as a narrative review, it does not report a systematic search strategy, formal study-quality assessment, or quantitative meta-analysis, which limits reproducibility and strength of conclusions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
53 Valid · 16 Not valid · 29 Not checked · 20 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“For example, clinical studies suggest that low BDNF methylation correlates with better SSRI response and high NR3C1 methylation predicts poorer CBT response in PTSD (56).”
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Clinical implications of epigenetics in psychiatry > Precision psychiatry and future directions
What the sources say
- Disputedcites [56] Yehuda, 2013, Epigenetic biomarkers as predictors and correlates of symptom improvement following psychotherapy in combat veterans with PTSD, Front Psychiatry sourceExperimental — accuracy not yet measured
The ‘Methylation of a GR Promoter’ section reports the opposite direction: veterans who responded had higher pretreatment NR3C1 promoter methylation than non-responders, and higher methylation corresponded to lower post-treatment PTSD symptom scores. The study examined prolonged exposure psychotherapy, not CBT; page numbers are unavailable in our copy. (LLM, conf=0.93)
Checked by a reasoning model — may be wrong.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“higher BDNF levels are associated with improved cognitive performance including memory, attention, and problem-solving”
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Clinically relevant epigenetically regulated genes in psychiatry > Brain-derived neurotrophic factor
What the sources say
- Partly supportedcites [60] Egan, 2003, The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function, Cell sourceExperimental — accuracy not yet measured
The Results (page unavailable) link BDNF genotype to verbal episodic-memory scores, and the Discussion links the variant to altered activity-dependent BDNF secretion. The paper does not establish that higher BDNF levels improve cognitive performance generally, including attention and problem-solving; the Results report no significant genotype effect on working memory or executive function. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In depression, altered chromatin accessibility have been observed at BDNF, GAD1, NR3C1 in response to stress”
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Epigenetic mechanisms in psychiatry > Chromatin remodeling
What the sources say
- Partly supportedcites [43] Labonté, 2012, Genome-wide epigenetic regulation by early-life trauma, Arch Gen Psychiatry sourceExperimental — accuracy not yet measured
The passage labeled Abstract (page unavailable) describes stress-related promoter hypermethylation involving BDNF, GAD1, and glucocorticoid-receptor variants, including methylation that constrains transcription-factor binding. It does not establish altered chromatin accessibility at all three genes in people with depression: the BDNF and GAD1 examples concern stressed rats, while the human example concerns suicide completers with childhood abuse. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In PTSD, increased COMT methylation is associated with impaired fear inhibition, which affects stress responsivity via dopamine regulation”
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Clinically relevant epigenetically regulated genes in psychiatry > Catechol-O-methyltransferase
What the sources say
- Partly supportedcites [79] Norrholm, 2013, Differential genetic and epigenetic regulation of catechol-O-methyltransferase is associated with impaired fear inhibition in posttraumatic stress disorder, Front Behav Neurosci sourceExperimental — accuracy not yet measured
The Results (Methylation) and Discussion report that higher COMT promoter methylation was associated with greater fear responses to a safety signal, consistent with impaired fear inhibition in the study’s traumatized participants. The Introduction describes COMT’s role in clearing dopamine, but the paper does not establish that the methylation-associated fear-inhibition difference affects stress responsivity through dopamine regulation. (LLM, conf=0.84)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“methylation of the COMT promoter has been associated with reduced gene expression in both brain and peripheral tissues, leading to increased dopamine availability in the prefrontal cortex”
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Clinically relevant epigenetically regulated genes in psychiatry > Catechol-O-methyltransferase
What the sources say
- Could not verifycites [75] Drabe, 2017, Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity, Transl Psychiatry sourceExperimental — accuracy not yet measured
The Results and Discussion passages concern methylation of the serotonin transporter gene (5-HTTLPR/SLC6A4) and prefrontal 5-HTT availability, not COMT or dopamine. Searches for COMT and COMT promoter methylation found no passage addressing reduced COMT expression in brain or peripheral tissue or increased prefrontal dopamine availability. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
77 more claims · 45 with their cited sources checked
Create a free account to see all 118 claims and every source verdict.
- It may state two separate claims as one. 34
- Probably not a substantial claim. 4
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Epigenetic mechanisms in psychiatry > Environmental influence on epigenetic changes
“In the case of early-life stress, commonly experienced through childhood abuse, DNA methylation of stress-regulating genes (i.e. NR3C1, FKBP5) increases, hypermethylating the glucocorticoid receptor and altering the HPA axis (10).”
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Clinically relevant epigenetically regulated genes in psychiatry > FK506 binding protein 5
“Stress exposure such as early-life stress decreases methylation of FKBP5 and upregulates FKBP5 gene expression which reduces GR sensitivity and may cause an exaggerated stress response (85).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Introduction
“These changes to the DNA sequence include epigenetic mechanisms that are readily reversible spanning from DNA methylation, histone modifications to non-coding RNAs and chromatin remodeling (3, 4).”
§ The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry > Epigenetic mechanisms in psychiatry
“Epigenetic modifications are readily reversible changes that influence gene expression without altering the DNA sequence (3).”
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325 · cited 2×
“These mechanisms act as molecular switches or dimmers, turning genes on or off in response to internal and external stimuli (7).”
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 1×
“The SLC6A4 gene encodes the serotonin transporter (SERT), a membrane protein responsible for the reuptake of serotonin (5-HT) from the synaptic cleft back into presynaptic neurons (100).”
DNA methylation and its basic function
Moore, L. D., Le, T., & Fan, G. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.112 · Cited by 4,906 · cited 1×
“…process by which DNA methyltransferases (DNMTs) catalyze the addition of a methyl group (-CH 3 ) to cytosine residues on the 5-carbon of the cytosine ring in CpG dinucleotides, cytosine-rich regions often near gene promoters, between genes (referred to as intergenic regions), or in gene bodies (8).”
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672 · cited 1×
“…gene expression post-transcriptionally by binding to target messenger RNAs (mRNAs) and suppress translation or promote mRNA degradation (29). miRNAs are both targets and regulators of epigenetic processes since they exist within a feedback loop with DNA methylation and histone modi fi cations (30).”
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531 · cited 2×
“In psychiatry, this dynamic process where methylation is readily added or removed occurs in response to developmental cues and environmental exposures such as stress, trauma, and aging (10).”
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763 · cited 1×
“As a G-protein-coupled receptor (GPCR), DRD2 is involved in modulating dopaminergic neurotransmission and plays a role as an inhibitory receptor by reducing neuronal excitability and dopamine synthesis via Gi/o protein coupling (109, 110).”
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · cited 1×
“Postsynaptic D2 receptor overactivation, resulting from increased presynaptic dopamine release in the nucleus accumbens (located in the ventral striatum), is central to the dopamine hypothesis of schizophrenia (116).”
Serotonin transporter genetic variation and the response of the human amygdala.
Hariri, A. R., Mattay, V. S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M. F., & Weinberger, D. R. (2002) · Science · doi:10.1126/science.1071829 · Cited by 2,340
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 1×
“Because methylation patterns are inherited through cell divisions, DNA methylation is said to affect cellular memory with gene expression states preserved across time and development (11).”
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241 · cited 1×
“In this context, gene expression is activated or silenced depending on the speci fi c sites and number of methyl groups (24).”
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023 · cited 1×
“Mental health is rooted in biological predispositions and experiences with genetic factors contributing to psychiatric disorders but not being able to fully explain differences in symptom onset, severity, and treatment response (1).”
Transposable elements: targets for early nutritional effects on epigenetic gene regulation
Waterland, R. A., & Jirtle, R. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5293-5300.2003 · Cited by 2,019
Epigenetics and the environment: emerging patterns and implications
Feil, R., & Fraga, M. F. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3142 · Cited by 1,929 · cited 1×
“Environmental epigenetics studies how external factors like stress, diet, toxins, infections, relationships, and experiences, can lead to long-lasting changes in gene expression by altering the epigenome (49).”
Genome-wide association study identifies five new schizophrenia loci
The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) · Nature Genetics · doi:10.1038/ng.940 · Cited by 1,919
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Binder (2004) · doi:10.1080/08977190410001723308 · Cited by 1,481 · cited 1×
“BDNF is a growth factor that supports neuroplasticity, neuronal survival, neurogenesis, and contributes to neural repair and recovery after brain injuries like stroke or trauma (58).”
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3275 · Cited by 1,447 · cited 1×
“Stress exposure such as early-life stress decreases methylation of FKBP5 and upregulates FKBP5 gene expression which reduces GR sensitivity and may cause an exaggerated stress response (85).”
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400 · cited 5×
“By examining well studied genes (including BDNF , COMT , FKBP5 , NR3C1 , SLC6A4 , and DRD2 ) implicated in psychiatry disorders, including major depressive disorder (MDD), bipolar disorder (BP), schizophrenia, post-traumatic stress disorder (PTSD), attention de fi cit/hyperactivity disorder (ADHD), autism spectrum diso…”
InfluentialMechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes
Clapier, C. R., Iwasa, J., Cairns, B. R., & Peterson, C. L. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.26 · Cited by 1,305 · cited 1×
“Chromatin remodeling controls the transition between euchromatin and heterochromatin thereby allowing or blocking gene expression (39).”
Editing DNA Methylation in the Mammalian Genome
Liu, X. S., Wu, H., Ji, X., Stelzer, Y., Wu, X., Czauderna, S., Shu, J., Dadon, D., Young, R. A., & Jaenisch, R. (2016) · Cell · doi:10.1016/j.cell.2016.08.056 · Cited by 1,224 · cited 13×
“In addition to HDAC inhibitors, several experimental miRNA-based therapies for psychiatric disorders like schizophrenia, MDD, anxiety, and neurodevelopmental disorders are currently under investigation (122).”
InfluentialCorces, M. R., Buenrostro, J. D., Wu, B., Greenside, P. G., Chan, S. M., Koenig, J. L., Snyder, M. P., Pritchard, J. K., Kundaje, A., Greenleaf, W. J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3646 · Cited by 1,151 · cited 1×
“Currently, chromatin accessibility pro fi ling (e.g., ATAC-seq) is being explored as a biomarker tool in psychiatry (44).”
Chromatin remodelling during development
Ho, L., & Crabtree, G. R. (2010) · Nature · doi:10.1038/nature08911 · Cited by 1,114 · cited 11×
“In addition to DNA and histone modi fi cations, BDNF expression is epigenetically regulated by miRNAs (including miR-132 and miR-206), which can bind BDNF mRNA and suppress translation.”
InfluentialMolecular mechanisms of drug addiction
Nestler, E. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.031 · Cited by 1,108
The Brain on Stress: Vulnerability and Plasticity of the Prefrontal Cortex over the Life Course
McEwen, B. S., & Morrison, J. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.028 · Cited by 1,079
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Long story short: the serotonin transporter in emotion regulation and social cognition
Canli, T., & Lesch, K.-P. (2007) · Nature Neuroscience · doi:10.1038/nn1964 · Cited by 1,034 · cited 1×
“SLC6A4 regulates serotonin availability in the brain, impacts mood, emotion, anxiety, and stress regulation, and is the main target of SSRIs used in treating MDD and anxiety disorders (101).”
Thakore, P. I., D'Ippolito, A. M., Song, L., Safi, A., Shivakumar, N. K., Kabadi, A. M., Reddy, T. E., Crawford, G. E., & Gersbach, C. A. (2015) · Nature Methods · doi:10.1038/nmeth.3630 · Cited by 1,012 · cited 1×
“They are currently being evaluated in preclinical models of PTSD, addiction, and MDD (125, 126).”
A novel pathway regulates memory and plasticity via SIRT1 and miR-134
Gao, J., Wang, W.-Y., Mao, Y.-W., Gräff, J., Guan, J.-S., Pan, L., Mak, G., Kim, D., Su, S. C., & Tsai, L.-H. (2010) · Nature · doi:10.1038/nature09271 · Cited by 975
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968 · cited 1×
“By altering GR sensitivity, FKBP5 plays a critical role in stress hormone regulation, in fl uencing the HPA axis, and impacting various psychiatric conditions (84).”
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms
Hargreaves, D. C., & Crabtree, G. R. (2011) · Cell Research · doi:10.1038/cr.2011.32 · Cited by 923 · cited 2×
“…chromatin (e.g., BRG1, BAF complex); (2) ISWI, which spaces nucleosomes for transcriptional regulation (e.g., SNF2H); (3) CHD, which contributes to nucleosome assembly and remodeling (e.g., CHD1, CHD8); and (4) INO80, which couples remodeling to DNA repair and replication (e.g., INO80, SRCAP) (40).”
Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875
Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology
Volkow, N. D., Wang, G.-J., Fowler, J. S., & Telang, F. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0107 · Cited by 809 · cited 1×
“DRD2 expression is observed at high levels in the striatum, prefrontal cortex, and limbic regions to regulate reward processing, motivation and reinforcement, cognitive control, movement and motor coordination (111).”
Turecki, G., & Meaney, M. J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.022 · Cited by 796 · cited 2×
“…trauma, in-utero exposures (medications, substances of abuse, starvation, viral exposure, toxoplasmosis), early-life adversity, social relationships, and lifestyle can alter gene expression without changing the DNA sequence and affects brain function and behavior is the basis for epigenetics (2).”
Epigenetic Regulation of bdnf Gene Transcription in the Consolidation of Fear Memory
Lubin, F. D., Roth, T. L., & Sweatt, J. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1786-08.2008 · Cited by 793 · cited 1×
“For example, exon IV of BDNF is highly sensitive to environmental signals and hypermethylation of BDNF promoter regions, especially exon IV, reduces BDNF expression (61).”
Distinct functions of the two isoforms of dopamine D2 receptors
Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717
Histone phosphorylation: A chromatin modification involved in diverse nuclear events
Rossetto, D., Avvakumov, N., & Côté, J. (2012) · Epigenetics · doi:10.4161/epi.21975 · Cited by 628
Antidepressant Actions of Histone Deacetylase Inhibitors
Covington, H. E., Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., Wu, E. Y., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1758-09.2009 · Cited by 624
Gene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622
Epigenetics and the environmental regulation of the genome and its function
Zhang, T.-Y., & Meaney, M. J. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.60.110707.163625 · Cited by 565
Reelin promoter hypermethylation in schizophrenia
Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., & Costa, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503736102 · Cited by 553
Methyl-cpG-binding domain proteins: readers of the epigenome
Du, Q., Luu, P.-L., Stirzaker, C., & Clark, S. J. (2015) · Epigenomics · doi:10.2217/epi.15.39 · Cited by 544 · cited 1×
“…chromatin structure and in fl uence transcription factor accessibility and RNA polymerase binding, often interacting with other epigenetic mechanisms like DNA methylation to synergistically promote or repress gene expression (for example, methylated DNA recruiting histone-modifying enzymes) (26).”
Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
Schroeder, F. A., Lin, C. L., Crusio, W. E., & Akbarian, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.036 · Cited by 541
Perroud, N., Paoloni-Giacobino, A., Prada, P., Olié, E., Salzmann, A., Nicastro, R., Guillaume, S., Mouthon, D., Stouder, C., Dieben, K., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.60 · Cited by 516
Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex
Jaffe, A. E., Gao, Y., Deep-Soboslay, A., Tao, R., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2016) · Nature Neuroscience · doi:10.1038/nn.4181 · Cited by 511 · cited 1×
“Although less well characterized, histone modi fi cations also affect COMT expression, and the general mechanisms such as histone acetylation and methylation are known to in fl uence gene expression in neuropsychiatric contexts (82).”
Genome-wide epigenetic regulation by early-life trauma
Labonté, B., Suderman, M., Maussion, G., Navaro, L., Yerko, V., Mahar, I., Bureau, A., Mechawar, N., Szyf, M., Meaney, M. J., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2287 · Cited by 488
Tyrka, A. R., Price, L. H., Marsit, C., Walters, O. C., & Carpenter, L. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030148 · Cited by 486
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462
Tsankova, N. M., Kumar, A., & Nestler, E. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0589-04.2004 · Cited by 447
DNA methylation of BDNF as a biomarker of early-life adversity
Kundakovic, M., Gudsnuk, K., Herbstman, J. B., Tang, D., Perera, F. P., & Champagne, F. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408355111 · Cited by 426
MicroRNAs in neuronal function and dysfunction
Im, H.-I., & Kenny, P. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.01.004 · Cited by 399 · cited 1×
“…by cell type, developmental stage, and environment, and they are also dynamic, changing in response to stress, drugs, experiences, and hormones (31). miRNAs are abundant in the brain and have crucial roles in neuronal development and differentiation, synaptic plasticity and learning, stress…”
Fernandes, B. S., Gama, C. S., Maria Ceresér, K., Yatham, L. N., Fries, G. R., Colpo, G., de Lucena, D., Kunz, M., Gomes, F. A., & Kapczinski, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.002 · Cited by 389 · cited 1×
“In BD, BDNF epigenetic changes are state-dependent, with lower levels during manic and depressive episodes compared with euthymia (65).”
Increased BDNF Promoter Methylation in the Wernicke Area of Suicide Subjects
Keller, S., Sarchiapone, M., Zarrilli, F., Videtič, A., Ferraro, A., Carli, V., Sacchetti, S., Lembo, F., Angiolillo, A., Jovanovic, N., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.9 · Cited by 379 · cited 1×
“Studies have reported reduced BDNF expression in people with MDD, PTSD, schizophrenia, and after early-life stress or childhood trauma (62).”
Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378
Gomez‐Pinilla, F., Zhuang, Y., Feng, J., Ying, Z., & Fan, G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07508.x · Cited by 367
Yehuda, R., Daskalakis, N. P., Desarnaud, F., Makotkine, I., Lehrner, A. L., Koch, E., Flory, J. D., Buxbaum, J. D., Meaney, M. J., & Bierer, L. M. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00118 · Cited by 358
Epigenetics of Stress-Related Psychiatric Disorders and Gene × Environment Interactions
Klengel, T., & Binder, E. B. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.036 · Cited by 353 · cited 3×
“…framework for understanding how environmental factors such as early-life adversity, trauma, social experiences, nutrition, disease, lifestyle (physical activity and quality of sleep), and therapeutic interventions, can shape brain function and contribute to the development of mental illness (5).”
Palma-Gudiel, H., Córdova-Palomera, A., Leza, J. C., & Fañanás, L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.016 · Cited by 347
Nagarajan, R., Hogart, A., Gwye, Y., Martin, M. R., & LaSalle, J. M. (2006) · Epigenetics · doi:10.4161/epi.1.4.3514 · Cited by 347
Weder, N., Zhang, H., Jensen, K., Yang, B. Z., Simen, A., Jackowski, A., Lipschitz, D., Douglas-Palumberi, H., Ge, M., Perepletchikova, F., et al. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.12.025 · Cited by 324
Issler, O., Haramati, S., Paul, E. D., Maeno, H., Navon, I., Zwang, R., Gil, S., Mayberg, H. S., Dunlop, B. W., Menke, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.042 · Cited by 318
van IJzendoorn, M. H., Caspers, K., Bakermans-Kranenburg, M. J., Beach, S. R. H., & Philibert, R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.008 · Cited by 264
The effects of early life stress on the epigenome: From the womb to adulthood and even before
Provençal, N., & Binder, E. B. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.001 · Cited by 255 · cited 1×
“Epigenetic markers like SLC6A4 or OXTR methylation can predict risk for MDD or anxiety after trauma and individual resilience pro fi les (127).”
Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression
Kang, H.-J., Kim, J.-M., Stewart, R., Kim, S.-Y., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Shin, M.-G., & Yoon, J.-S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.01.006 · Cited by 254
Molecular genetics of attention-deficit/hyperactivity disorder: an overview
Banaschewski, T., Becker, K., Scherag, S., Franke, B., & Coghill, D. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0090-z · Cited by 252 · cited 1×
“In ADHD, DRD2 polymorphisms and methylation status are linked to impulsivity and dopaminergic dysfunction (119).”
Blood microRNA changes in depressed patients during antidepressant treatment
Bocchio-Chiavetto, L., Maffioletti, E., Bettinsoli, P., Giovannini, C., Bignotti, S., Tardito, D., Corrada, D., Milanesi, L., & Gennarelli, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.013 · Cited by 238
Reelin expression and glycosylation patterns are altered in Alzheimer’s disease
Botella-López, A., Burgaya, F., Gavín, R., García-Ayllón, M. S., Gómez-Tortosa, E., Peña-Casanova, J., Ureña, J. M., Del Río, J. A., Blesa, R., Soriano, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601279103 · Cited by 221 · cited 1×
“Studies in PTSD and suicidality demonstrate that early-life trauma is associated with long-lasting BDNF promoter methylation, affecting stress reactivity and fear extinction, and for suicide victims, BDNF promoter hypermethylation is observed in the prefrontal cortex and hippocampus (66 – 68).”
Abdolmaleky, H. M., Smith, C. L., Faraone, S. V., Shafa, R., Stone, W., Glatt, S. J., & Tsuang, M. T. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20142 · Cited by 216
Furmark, T., Appel, L., Henningsson, S., Åhs, F., Faria, V., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2534-08.2008 · Cited by 210
Child maltreatment and the development of substance use and disorder
Cicchetti, D., & Handley, E. D. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.100144 · Cited by 210
MiR-137: an important player in neural development and neoplastic transformation
Mahmoudi, E., & Cairns, M. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.150 · Cited by 198
Menke, A., Arloth, J., Pütz, B., Weber, P., Klengel, T., Mehta, D., Gonik, M., Rex-Haffner, M., Rubel, J., Uhr, M., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.331 · Cited by 177
Booij, L., Szyf, M., Carballedo, A., Frey, E.-M., Morris, D., Dymov, S., Vaisheva, F., Ly, V., Fahey, C., Meaney, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119061 · Cited by 174
Increased OPRM1 DNA Methylation in Lymphocytes of Methadone-Maintained Former Heroin Addicts
Nielsen, D. A., Yuferov, V., Hamon, S., Jackson, C., Ho, A., Ott, J., & Kreek, M. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.108 · Cited by 172
Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders
Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171
Nohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M.-R., Ahmadkhaniha, H., Thiagalingam, S., & Abdolmaleky, H. M. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.06.013 · Cited by 168
Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia
Bryois, J., Garrett, M. E., Song, L., Safi, A., Giusti-Rodriguez, P., Johnson, G. D., Shieh, A. W., Buil, A., Fullard, J. F., Roussos, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05379-y · Cited by 167
Acetyl- l -carnitine deficiency in patients with major depressive disorder
Nasca, C., Bigio, B., Lee, F. S., Young, S. P., Kautz, M. M., Albright, A., Beasley, J., Millington, D. S., Mathé, A. A., Kocsis, J. H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801609115 · Cited by 152
Epigenetics of early-life lead exposure and effects on brain development
Senut, M.-C., Cingolani, P., Sen, A., Kruger, A., Shaik, A., Hirsch, H., Suhr, S. T., & Ruden, D. (2012) · Epigenomics · doi:10.2217/epi.12.58 · Cited by 151
Brain-Derived Neurotrophic Factor
Binder, D. K. (2003) · Elsevier eBooks · doi:10.1016/b0-12-341103-3/00037-1 · Cited by 147
Xia, C., Tao, Y., Li, M., Che, T., & Qu, J. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9073 · Cited by 136
Epigenetics of drug abuse: predisposition or response
Nielsen, D. A., Utrankar, A., Reyes, J. A., Simons, D. D., & Kosten, T. R. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.94 · Cited by 125 · cited 1×
“Studies in substance use disorders including cocaine, alcohol, and nicotine show that substance use can alter DRD2 methylation in animal and human (118).”
Okada, S., Morinobu, S., Fuchikami, M., Segawa, M., Yokomaku, K., Kataoka, T., Okamoto, Y., Yamawaki, S., Inoue, T., Kusumi, I., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.002 · Cited by 125
The emerging role of microRNAs in schizophrenia and autism spectrum disorders
Mellios, N., & Sur, M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00039 · Cited by 120
Epigenetic mechanisms of drug addiction
Feng, J., & Nestler, E. J. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.001 · Cited by 113 · cited 1×
“In the context of the epigenome, DNA methylation plays a central role in important biological processes including embryonic development, X-chromosome inactivation, imprinting, tissue-speci fi c gene expression, and brain plasticity (12).”
Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis
Qureshi, I. A., & Mehler, M. F. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.02.005 · Cited by 112 · cited 1×
“These changes to the DNA sequence include epigenetic mechanisms that are readily reversible spanning from DNA methylation, histone modi fi cations to non-coding RNAs and chromatin remodeling (3, 4).”
Dell׳Osso, B., D׳Addario, C., Carlotta Palazzo, M., Benatti, B., Camuri, G., Galimberti, D., Fenoglio, C., Scarpini, E., Di Francesco, A., Maccarrone, M., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.020 · Cited by 112 · cited 1×
“In BD, epigenetic signatures are often state-dependent, with methylation differing in manic and depressive states compared to euthymic states (16).”
Histone acetylation in drug addiction
Renthal, W., & Nestler, E. J. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.01.005 · Cited by 109 · cited 1×
“Histone acetyltransferases (HATs) add acetyl groups to lysine residues on histone tails, a modi fi cation referred to as acetylation (22).”
Viana, J., Hannon, E., Dempster, E., Pidsley, R., Macdonald, R., Knox, O., Spiers, H., Troakes, C., Al-Saraj, S., Turecki, G., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw373 · Cited by 105
Norrholm, S. D., Jovanovic, T., Smith, A. K., Binder, E., Klengel, T., Conneely, K., Mercer, K. B., Davis, J. S., Kerley, K., Winkler, J., et al. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00030 · Cited by 104
Bishop, J. R., Lee, A. M., Mills, L. J., Thuras, P. D., Eum, S., Clancy, D., Erbes, C. R., Polusny, M. A., Lamberty, G. J., & Lim, K. O. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00418 · Cited by 98
Environmental programming of susceptibility and resilience to stress in adulthood in male mice
Peña, C. J., Nestler, E. J., & Bagot, R. C. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00040 · Cited by 97 · cited 1×
“With the advent of precision psychiatry and personalized medicine, understanding an individual ’ s epigenetic pro fi le is essential, and when used in combination with genetic factors and their environmental history can open the door to targeted interventions and aid in better treatment response (6).”
Cell biology of BDNF and its relevance to schizophrenia
Lu, B., & Martinowich, K. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470751251.ch10 · Cited by 92
Mooney, M. A., Ryabinin, P., Wilmot, B., Bhatt, P., Mill, J., & Nigg, J. T. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0710-4 · Cited by 91
Fang, Y., Qiu, Q., Zhang, S., Sun, L., Li, G., Xiao, S., & Li, X. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.090 · Cited by 90 · cited 1×
“Other studies have reported that plasma miR-124 levels increase after citalopram treatment relative to untreated controls (35).”
Krol, K. M., Puglia, M. H., Morris, J. P., Connelly, J. J., & Grossmann, T. (2019) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2019.100648 · Cited by 86
FKBP5 allele-specific epigenetic modification in gene by environment interaction
Klengel, T., & Binder, E. B. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.208 · Cited by 84
BDNF genetic variants and methylation: effects on cognition in major depressive disorder
Ferrer, A., Labad, J., Salvat-Pujol, N., Barrachina, M., Costas, J., Urretavizcaya, M., de Arriba-Arnau, A., Crespo, J. M., Soriano-Mas, C., Carracedo, Á., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0601-8 · Cited by 84
Schuebel, K., Gitik, M., Domschke, K., & Goldman, D. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw058 · Cited by 75 · cited 2×
“These changes to the DNA sequence include epigenetic mechanisms that are readily reversible spanning from DNA methylation, histone modi fi cations to non-coding RNAs and chromatin remodeling (3, 4).”
Cell-type-specific epigenetic effects of early life stress on the brain
Rahman, M. F., & McGowan, P. O. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02076-9 · Cited by 75 · cited 1×
“These therapies focus on reversing stress-induced gene silencing, and studies demonstrate that such interventions can alleviate symptoms of MDD, anxiety, PTSD, while enhancing cognitive resilience (124).”
Hohne, N., Poidinger, M., Merz, F., Pfister, H., Bruckl, T., Zimmermann, P., Uhr, M., Holsboer, F., & Ising, M. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu087 · Cited by 74
Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients
Yu, H.-C., Wu, J., Zhang, H.-X., Zhang, G.-L., Sui, J., Tong, W.-W., Zhang, X.-Y., Nie, L.-L., Duan, J.-H., Zhang, L.-R., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.007 · Cited by 71
Kleimann, A., Kotsiari, A., Sperling, W., Gröschl, M., Heberlein, A., Kahl, K. G., Hillemacher, T., Bleich, S., Kornhuber, J., & Frieling, H. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1336-6 · Cited by 70 · cited 1×
“In depression, studies report low peripheral BDNF levels and higher promoter methylation, while antidepressants and electroconvulsive therapy (ECT) increase BDNF expression and reverse methylation (63, 64).”
Environmental exposure and mitochondrial epigenetics: study design and analytical challenges
Byun, H.-M., & Baccarelli, A. A. (2014) · Human Genetics · doi:10.1007/s00439-013-1417-x · Cited by 68 · cited 1×
“Toxins and pollutants can alter the epigenome by inducing oxidative stress and disrupting methylation machinery, and in the brain, bisphenol A (BPA), lead, and air pollution alter methylation in brain development genes (52 – 54).”
Longitudinal multi-level biomarker analysis of BDNF in major depression and bipolar disorder
Schröter, K., Brum, M., Brunkhorst-Kanaan, N., Tole, F., Ziegler, C., Domschke, K., Reif, A., & Kittel-Schneider, S. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01007-y · Cited by 68
Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence
Zhang, H., Herman, A. I., Kranzler, H. R., Anton, R. F., Simen, A. A., & Gelernter, J. E. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.98 · Cited by 67
DNA methylation of FKBP5 and response to exposure-based psychological therapy
Roberts, S., Keers, R., Breen, G., Coleman, J. R. I., Jöhren, P., Kepa, A., Lester, K. J., Margraf, J., Scheider, S., Teismann, T., et al. (2019) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32650 · Cited by 67
Shi, S., Leites, C., He, D., Schwartz, D., Moy, W., Shi, J., & Duan, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.535203 · Cited by 61
Kim, S. S., Truong, B., Jagadeesh, K., Dey, K. K., Shen, A. Z., Raychaudhuri, S., Kellis, M., & Price, A. L. (2024) · Nature Communications · doi:10.1038/s41467-024-44742-0 · Cited by 56
Maurel, O. M., Torrisi, S. A., Barbagallo, C., Purrello, M., Salomone, S., Drago, F., Ragusa, M., & Leggio, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105157 · Cited by 44
Catechol‐O‐methyltransferase gene methylation and substance use in adolescents: the TRAILS study
van der Knaap, L. J., Schaefer, J. M., Franken, I. H. A., Verhulst, F. C., van Oort, F. V. A., & Riese, H. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12147 · Cited by 38 · cited 1×
“In the context of environmental interactions, cigarette smoking is associated with hypermethylation of the MB-COMT promoter, while cannabis use interacts with the COMT Val158Met genotype/epigenotype to in fl uence psychosis risk (80, 81).”
Genome-wide DNA methylation in suicide victims revealing impact on gene expression
Kouter, K., Zupanc, T., & Videtič Paska, A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.077 · Cited by 36
Xu, Q. (2010) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2010.00016 · Cited by 32
Drabe, M., Rullmann, M., Luthardt, J., Boettcher, Y., Regenthal, R., Ploetz, T., Becker, G. A., Patt, M., Schinke, C., Bergh, F. T., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.133 · Cited by 32
Duttke, S. H., Montilla-Perez, P., Chang, M. W., Li, H., Chen, H., Carrette, L. L. G., Guglielmo, G. D., George, O., Palmer, A. A., Benner, C., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.858427 · Cited by 26
Cruz, B., Vozella, V., Carper, B. A., Xu, J. C., Kirson, D., Hirsch, S., Nolen, T., Bradley, L., Fain, K., Crawford, M., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01497-w · Cited by 25
Mohammadi, S., Beh-Pajooh, A., Ahmadimanesh, M., Amini, M., Ghazi-Khansari, M., Moallem, S. A., Hosseini, R., Nourian, Y. H., & Ghahremani, M. H. (2022) · Epigenomics · doi:10.2217/epi-2022-0246 · Cited by 23
Wiegand, A., Blickle, A., Brückmann, C., Weller, S., Nieratschker, V., & Plewnia, C. (2021) · Biomolecules · doi:10.3390/biom11111726 · Cited by 19
An allostatic epigenetic memory on chromatin footprints after double-hit acute stress
Caradonna, S. G., Paul, M. R., & Marrocco, J. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100475 · Cited by 13 · cited 1×
“Stress has also been shown to in fl uence chromatin accessibility at the FKBP5 locus, although this area remains less well characterized than DNA methylation (87).”
Seo, J. H., Kim, S. T., Jeon, S., Kang, J. I., & Kim, S. J. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106404 · Cited by 11
Zhou, J., Zhou, D., Yan, T., Chen, W., Xie, H., & Xiong, Y. (2022) · Journal of International Medical Research · doi:10.1177/03000605221100345 · Cited by 9
He, C., Wang, Q., Fan, D., Liu, X., Bai, Y., Zhang, H., Zhang, H., Yao, H., Zhang, Z., & Xie, C. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104025 · Cited by 8
Evaluation of chromatin accessibility in prefrontal cortex of schizophrenia cases and controls
Bryois, J., Garrett, M. E., Song, L., Safi, A., Giusti-Rodriguez, P., Johnson, G. D., Demur, A. B., Fullard, J. F., Roussos, P., Sklar, P., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/141986 · Cited by 7
Zou, Z., Huang, Y., Maes, M., Wang, J., He, Y., Min, W., & Zhou, B. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05704-4 · Cited by 4
Ni, L., Zhu, Y., Lv, L., Zhang, R., Xie, S., & Zhang, X. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.126 · Cited by 3
Cited by
Makarewicz, A., Recław, R., Grzywacz, A., Chmielowiec, J., & Chmielowiec, K. (2026) · Brain Sciences · doi:10.3390/brainsci16020187 · Cited by 2
Concurrent Serial Feature Negative and Simple Discrimination Training and Testing in the Mouse
Ardabili, N. G., Pettiford, J., Hyde, A., Airosus, C., Riley, A. L., & Davidson, T. L. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116100
Epigenetics of bipolar disorder: a bibliometric landscape and visualization analysis
Xiong, L., Fan, H., Gao, J., & Lei, M. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1804155
Advancing Our Understanding of Depression—From Molecular Mechanisms to Novel Therapeutic Frontiers
Kisková, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188069
Metadata
- Authors
- Montel Hayes, R., Mason, C. E., & Miller, J. J.
- Affiliations
- Cornell University (US)
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2025-10-29
- Volume
- 16
- Pages
- 1671122-1671122
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC12605923
- OpenAlex
- W4415663958
- Cited by
- 5
- References
- 131
- Citations by year
- 2026: 5
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- epigenetics, mental illness, precision psychiatry, DNA methylation, histone modifications, non-coding RNA, candidate genes, brain-derived neurotrophic factor, catechol-O-methyltransferase, FKBP5, NR3C1, serotonin transporter, DRD2, schizophrenia, major depressive disorder, bipolar disorder, post-traumatic stress disorder, autism spectrum disorder, epigenetic biomarkers, personalized treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.